Target- |
MechanismNatural killer cell replacements |
|
|
|
|
Drug Highest PhasePhase 2 |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Avaris AB
0 Patents (Medical) associated with Avaris AB
100 Deals associated with Avaris AB
100 Translational Medicine associated with Avaris AB